Director Lisa Wardell Sells 54,207 Shares of Adtalem Global Education Inc (ATGE)

Article's Main Image

On September 4, 2024, Lisa Wardell, Director at Adtalem Global Education Inc (ATGE, Financial), executed a sale of 54,207 shares of the company. The transaction was filed on the same day through an SEC Filing. Following this transaction, the insider now owns 105,085 shares of Adtalem Global Education Inc.

Adtalem Global Education Inc is a provider of educational services. The company offers programs in medical and healthcare, financial services, and business and law, among other fields. It operates several institutions, including Chamberlain University, Ross University School of Medicine, and Becker Professional Education.

Over the past year, Lisa Wardell has sold a total of 535,544 shares and has not made any purchases of the company's stock. This recent sale is part of a broader trend observed within the company, where there have been 10 insider sells and no insider buys over the past year.

Shares of Adtalem Global Education Inc were priced at $73.79 on the day of the transaction. The company has a market cap of approximately $2.72 billion. The price-earnings ratio stands at 21.13, which is above the industry median of 17.27.

According to the GF Value, the intrinsic value of Adtalem Global Education Inc is estimated at $56.46 per share, making the stock modestly overvalued with a price-to-GF-Value ratio of 1.31.

1831814940206460928.png

1831814955356286976.png

The GF Value is calculated based on historical trading multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted for the company's past performance and expected future business outcomes.

This insider sale might interest investors tracking insider behaviors as an indicator of the company's future prospects and valuation alignment.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.